Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry J Sacks

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
American Journal of Rhinology|September 22, 2007
Onset of action of azelastine nasal spray compared with mometasone nasal spray and placebo in subjects with seasonal allergic rhinitis evaluated in an environmental exposure chamberPiyush Patel, Carrie D'Andrea, Harry J Sacks
Current Medical Research and Opinion|November 14, 2009
Randomized, double-blind trial of carisoprodol 250 mg compared with placebo and carisoprodol 350 mg for the treatment of low back spasmGregory T Serfer, William J Wheeler, Harry J Sacks
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 3, 2007
FluorofelbamateBryan A Roecklein, Harry J Sacks, Henry Mortko, et al.
Ear, Nose, & Throat Journal|April 19, 2022
The Effect of EDS-FLU on Objective and Patient-Reported Subjective Outcomes for Patients with Chronic Rhinosinusitis with Nasal PolypsRandall A Ow, John P McGinnis, Harry J Sacks, et al.
Allergy and Asthma Proceedings|November 10, 2021
Evaluation of the ocular safety associated with the exhalation delivery system with fluticasoneDavid P Skoner, Eli O Meltzer, Jonathan Skoner, et al.
American Journal of Rhinology & Allergy|October 8, 2009
Double-blind, placebo-controlled trial of reformulated azelastine nasal spray in patients with seasonal allergic rhinitisJonathan A Bernstein, Bruce Prenner, Berrylin J Ferguson, et al.
The Journal of Allergy and Clinical Immunology|August 10, 2025
Effect of dupilumab on small airways measured by airway oscillometry in VESTIGEGeorge R Washko, Brian J Lipworth, Dinesh Saralaya, et al.
Allergy|June 23, 2025
Burden of Oral Corticosteroid Use in Severe Asthma: Challenges and OpportunitiesG Walter Canonica, Celeste Porsbjerg, David B Price, et al.
Advances in Therapy|April 30, 2026
Coexisting Type 2 Inflammatory Conditions in Patients with Asthma Treated with Dupilumab: the RAPID RegistryAnju T Peters, Andréanne Côté, Xavier Muñoz, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|August 6, 2025
Impact of asthma age of onset or duration on efficacy of dupilumab in moderate-to-severe type 2 asthmaWilliam W Busse, Monica Kraft, Christian Domingo, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
American Journal of Rhinology|September 22, 2007
Onset of action of azelastine nasal spray compared with mometasone nasal spray and placebo in subjects with seasonal allergic rhinitis evaluated in an environmental exposure chamberPiyush Patel, Carrie D'Andrea, Harry J Sacks
Current Medical Research and Opinion|November 14, 2009
Randomized, double-blind trial of carisoprodol 250 mg compared with placebo and carisoprodol 350 mg for the treatment of low back spasmGregory T Serfer, William J Wheeler, Harry J Sacks
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 3, 2007
FluorofelbamateBryan A Roecklein, Harry J Sacks, Henry Mortko, et al.
Ear, Nose, & Throat Journal|April 19, 2022
The Effect of EDS-FLU on Objective and Patient-Reported Subjective Outcomes for Patients with Chronic Rhinosinusitis with Nasal PolypsRandall A Ow, John P McGinnis, Harry J Sacks, et al.
Allergy and Asthma Proceedings|November 10, 2021
Evaluation of the ocular safety associated with the exhalation delivery system with fluticasoneDavid P Skoner, Eli O Meltzer, Jonathan Skoner, et al.
American Journal of Rhinology & Allergy|October 8, 2009
Double-blind, placebo-controlled trial of reformulated azelastine nasal spray in patients with seasonal allergic rhinitisJonathan A Bernstein, Bruce Prenner, Berrylin J Ferguson, et al.
The Journal of Allergy and Clinical Immunology|August 10, 2025
Effect of dupilumab on small airways measured by airway oscillometry in VESTIGEGeorge R Washko, Brian J Lipworth, Dinesh Saralaya, et al.
Allergy|June 23, 2025
Burden of Oral Corticosteroid Use in Severe Asthma: Challenges and OpportunitiesG Walter Canonica, Celeste Porsbjerg, David B Price, et al.
Advances in Therapy|April 30, 2026
Coexisting Type 2 Inflammatory Conditions in Patients with Asthma Treated with Dupilumab: the RAPID RegistryAnju T Peters, Andréanne Côté, Xavier Muñoz, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|August 6, 2025
Impact of asthma age of onset or duration on efficacy of dupilumab in moderate-to-severe type 2 asthmaWilliam W Busse, Monica Kraft, Christian Domingo, et al.
Pageof 2